Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): June 10, 2013

 

 

BIOAMBER INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-35905   98-0601045

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

1250 Rene Levesque West, Suite 4110

Montreal, Quebec, Canada H3B 4W8

 

3850 Lane North, Suite 180

Plymouth, Minnesota 55447

(Address of principal executive offices)

Registrant’s telephone number, including area code (514) 844-8000

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 8.01 Other Events.

BioAmber Inc. (the “Company”) announced today that on June 10, 2013, the French Autorité des marchés financiers approved the Company’s prospectus for admission of its common stock to listing and trading on the Professional Segment of NYSE Euronext Paris under the symbol “BIOA.” The Company’s common stock will commence trading on the NYSE Euronext Paris on June 11, 2013.

A copy of the Press Release issued by the Company announcing the separation of the units is attached hereto as Exhibit 99.1.

 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

Exhibits

Number

  

Description

99.1    Press Release, dated June 10, 2013, issued by BioAmber Inc.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: June 10, 2013   BIOAMBER INC.
  By:  

/s/ Jean-François Huc

    Jean-François Huc
    President, Chief Executive Officer and Director


Exhibit Index

 

Exhibits

Number

  

Description

99.1    Press Release, dated June 10, 2013, issued by BioAmber Inc.